VEDANTA BIOSCIENCES INC.

In News

Vedanta Downsizes by 20% After Phase II Stumble in Ulcerative Colitis - BioSpace

BioSpace - Aug 14, 2025

PureTech Founded Entity Vedanta Biosciences Announces Phase 2 Study of VE202 in Ulcerative Colitis Did Not Meet Primary Endpoint - Yahoo Finance

Yahoo Finance - Aug 13, 2025

Vedanta, PureTech’s microbiome startup, to cut staff after study setback - BioPharma Dive

BioPharma Dive - Aug 14, 2025

Vedanta's live bacteria cocktail fails to reduce ulcerative colitis severity in phase 2 trial - Fierce Biotech

Fierce Biotech - Aug 13, 2025

Vedanta Biosciences raises $106.5M for microbiome therapy - Labiotech.eu

Labiotech.eu - Apr 27, 2023

Microbiome Disease Clinical Trial Analysis: Key Insights - GlobeNewswire

GlobeNewswire - Mar 04, 2025

21 Mass. life science companies must pay back tax breaks for failing to meet hiring goals - The Business Journals

The Business Journals - Oct 24, 2025

Vedanta Biosciences doses first subject in Phase III C difficile prevention trial - Clinical Trials Arena

Clinical Trials Arena - May 22, 2024

Vedanta awarded new funding from CARB-X to advance VE-707 - BioWorld MedTech

BioWorld MedTech - May 02, 2024

The Week’s 10 Biggest Funding Rounds: Biotech Goes Big, Orbital Leads The Way - Crunchbase News

Crunchbase News - Apr 28, 2023

Microbiome Therapeutics Market Size to Hit USD 3,405.99 Million by 2034 - Precedence Research

Precedence Research - Nov 24, 2025

Vedanta Biosciences Announces $25 Million Investment from Pfizer Inc. - Business Wire

Business Wire - Jan 12, 2021

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment